【正文】
her fasting glucose levels vs lisinopril or amlodipine arms in all patients and in nondiabetics – Impact of chlorthalidone on diabetes and cardiovascular disease may not be fully manifested in the relatively short followup period of 4 years – ACE inhibitors have previously been associated with a reduction in the development of diabetes and the progression of diabetic nephropathy Addon therapy – ACE inhibitor arm potentially at a disadvantage since the first addon therapy specified by the trial treatment algorithm for this arm was a betablocker rather than a diuretic or calcium channel blocker, both of which are more monly used in clinical practice Large crossover rate by 4 year followup